Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Indomo has raised $25.0M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Indomo's investors include Foresite Capital, Polaris Partners, Atomic.
Indomo is headquartered in San Francisco, United States.
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Indomo is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Indomo — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/indomo. Accessed October 31, 2026.
VCBacked. (2025). Indomo — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/indomo
{{cite web |title=Indomo — Funding & Investors |url=https://www.vcbacked.co/company/indomo |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated